Author

E. Segrist

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

D. Schultz· 1 shared H. Ramage· 1 shared J. S. Lee· 1 shared K. Jurado· 1 shared K. Samby· 1 shared K. Whig· 1 shared M. Dittmar· 1 shared M. Li· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

D. Schultz

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Drug repurposing screens reveal FDA approved drugs active against SARS-Cov-2

M. Dittmar, J. S. Lee, K. Whig, E. Segrist, M. Li, K. Jurado, K. Samby, H. Ramage, D. Schultz, S. Cherry

The paper screens FDA-approved drugs against SARS-CoV-2 in different cell types, identifying three FDA-approved antivirals with potential for clinical use.

bioRxiv · Jun 19, 2020 · PreprintMicrobiology